CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 73 enrolled
Drug / intervention
Eye Patchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05462821
NCT05462821Phase 3Completed
CompareCT.gov

Randomized Trial of Full-Time Occlusion Therapy for Intermittent Exotropia in Children

Jaeb Center for Health Research·interventional·Posted Jul 18, 2022·Updated Dec 2, 2025

In Brief

A Phase 3 clinical trial evaluating Eye Patch for Intermittent Exotropia. Completed, enrolled 73 participants across 25 sites.

Detailed Summary

Determine whether full-time patching is more effective than observation for improving distance control of IXT after 3 months of treatment (on-treatment outcome).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntermittent Exotropia
CountriesUnited States
CollaboratorsNational Eye Institute (NEI), Pediatric Eye Disease Investigator Group

Timeline

Phase 3CompletedFinished
2023202420252026
First PostedJul 18, 2022
Enrollment StartNov 1, 2022
Primary CompletionMay 1, 2025
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.0 years ago

Interventions

Eye Patchdevice

adhesive patch to cover eye